Labcorp released third-quarter 2026 financial results
Labcorp Holdings Inc. reported financial results for the third quarter ended September 30, 2026. The company invested $255.5 million in acquisitions and paid $58.2 million in dividends.
Financial results and development.
The company reported performance results for the quarter ended September 30, 2026. During this period, Labcorp invested $255.5 million in acquisitions and paid $58.2 million in dividends.
Third-quarter 2026 expenditures.
Revenue by quarter, $B
Sector context: 36 covered companies in Health Care reported a median revenue change of +7.2% YoY in their latest filings.
Future acquisitions.
The company signed agreements to acquire select assets of BioReference Health, the prenatal health testing business of Myriad Genetics, and Millennium Health. The transactions are subject to regulatory approval and customary closing conditions.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Labcorp
A notification in your browser or on your phone when we publish about Labcorp. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
